EXTRAWELL PHAR: Interim Report 2023/24
Futu NewsDec 18, 2023 03:30 ET · Announcements
Extrawell Pharmaceutical Swings to Fiscal H1 Loss on Fair Value Losses
Extrawell Pharmaceutical Holdings (HKG:0858) swung to an attributable loss of HK$237.7 million, or HK$0.0995 per share, in the fiscal first half, from a profit of HK$45.8 million, or HK$0.0192 per sha
MT NewswiresNov 30, 2023 02:16 ET
EXTRAWELL PHAR: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
Futu NewsNov 29, 2023 08:40 ET · Announcements
Extrawell Pharmaceutical: Change in Fair Value of Financial Assets Weighed on Results
Extrawell Pharmaceutical: Change in Fair Value of Financial Assets Weighed on Results
Dow JonesNov 12, 2023 17:06 ET
Extrawell Pharmaceutical: 1H Loss Likely Between HK$235.0M to HK$240.0M Vs. HK$46.0M Profit Year Ago
Extrawell Pharmaceutical: 1H Loss Likely Between HK$235.0M to HK$240.0M Vs. HK$46.0M Profit Year Ago
Dow JonesNov 12, 2023 17:05 ET
Extrawell Pharmaceutical Expects to Swing to Loss for 1H Ended September
Extrawell Pharmaceutical Expects to Swing to Loss for 1H Ended September
Dow JonesNov 12, 2023 17:04 ET
Premium Pharmaceutical (00858.HK) Profit Alert: Expected to lose about HK$235 million to HK$240 million in the medium term
On November 10, Gelonghui Pharmaceutical (00858.HK) announced that the company expects to record a loss of about HK$235 million and HK$240 million in the six months ending September 30, 2023, compared to a profit of about HK$46 million in the same period last year. It is expected that the conversion of profit to loss during the current period is mainly due to non-cash items, losses arising from changes in the fair value of financial assets (that is, group convertible bond investments) that are included in profit and loss at fair value, while income from changes in fair value was recorded during the corresponding period in 2022.
Gelonghui FinanceNov 10, 2023 06:18 ET
EXTRAWELL PHAR: Annual Report 2023
Futu NewsJul 28, 2023 04:30 ET · Announcements
Extrawell Pharmaceutical Amends Terms of Convertible Bonds by Innovative Pharmaceutical Biotech
Extrawell Pharmaceutical Holdings (HKG:0858) issued a third amended and restated instrument to modify the terms of certain convertible bonds issued by Innovative Pharmaceutical Biotech to the company.
MT NewswiresJul 12, 2023 09:11 ET
Extrawell Pharmaceutical's Fiscal Year 2023 Attributable Profit Falls
Extrawell Pharmaceutical Holdings' (HKG:0858) attributable profit fell to HK$129.3 million, or HK$0.0541 per share, in the fiscal year ended March 31, from HK$130.6 million, or HK$0.0546 per share, a
MT NewswiresJun 29, 2023 23:31 ET
Jingyou Pharmaceutical Announces Annual Results Shareholders' Shareholders' Profit of HK$129 Million Decreased 1.01% YoY
Jingyou Pharmaceutical (00858) announced financial results for the year ended March 31, 2023, with revenue of HK$72.577 million, a decrease of 1.82%; profit attributable to company owners was about HK$129 million, a decrease of 1.01%; basic profit per share was HK$5.41 cents.
新浪港股Jun 29, 2023 20:21 ET
The annual net profit of Jingyou Pharmaceutical (00858.HK) fell 1.01% to HK$129 million
GLONGHUI, June 29丨Jingyou Pharmaceutical (00858.HK) announced that for the year ending March 31, 2023, the company's revenue was HK$72.577 million, a decrease of 1.82% over the previous year; the company's shareholders' profit for the period was HK$129 million, a decrease of 1.01% over the previous year; and the basic profit per share was HK$5.41 cents. Although earnings remained relatively stable, there was a decline in gross profit due to the government imposing mandatory factory blockade measures in Changchun City (including the Group's local production plant) from March to May 2022, which led to a decline in production. Coupled with transportation and logistics restrictions and travel restrictions
Gelonghui FinanceJun 29, 2023 10:57 ET
EXTRAWELL PHAR: ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2023
Futu NewsJun 29, 2023 10:50 ET · Announcements
Extrawell Pharmaceutical Unit Completes Share Buyback Deal
Extrawell Pharmaceutical Holdings (HKG:0858) unit Changchun Extrawell completed the repurchase and subsequent cancellation of its own shares from vendor Jilin Zeyuan Industrial for 4.4 million yuan, a
MT NewswiresJun 20, 2023 03:05 ET
Extrawell Pharmaceutical to Swing to Loss in FY23
Extrawell Pharmaceutical Holdings (HKG:0858) expects a loss of about HK$190 million for the year ended March 31, as compared to a profit last year, the pharmaceutical products trader said Friday. The
MT NewswiresJun 16, 2023 06:31 ET
EXTRAWELL PHAR: PROFIT WARNING
Futu NewsJun 16, 2023 04:36 ET · Announcements
EXTRAWELL PHAR: DATE OF BOARD MEETING
Futu NewsJun 15, 2023 00:00 ET · Announcements
Jingyou Pharmaceutical: Interim Report 2022/23
moomoo NewsDec 15, 2022 03:44 ET · Announcements
Extrawell Pharmaceutical's Profit for Six Months Through September Nearly Halves
02:08 AM EST, 11/30/2022 (MT Newswires) -- Extrawell Pharmaceutical Holdings' (HKG:0858) attributable profit nearly halved to HK$45.8 million ($5.9 million), or HK$0.0162 per diluted share, for the si
MT NewswiresNov 30, 2022 02:11 ET
Excellent Pharmaceutical Industry: interim results for the six months ended September 30, 2022
moomoo NewsNov 29, 2022 06:51 ET · Announcements
No Data
No Data